Geron Stock Based Compensation from 2010 to 2024

GERN Stock

USD 4.17 0.11 2.71%

Geron Stock Based Compensation yearly trend continues to be very stable with very little volatility. Stock Based Compensation is likely to grow to about 20.3 M this year. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2002-03-31

Previous Quarter

12.6 M

Current Value

-17.4 M

Quarterly Volatility

3.2 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Geron financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Geron's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 8.7 M or Selling General Administrative of 72.6 M, as well as many indicators such as Price To Sales Ratio of 5.3 K, Dividend Yield of 0.0 or PTB Ratio of 2.86. Geron financial statements analysis is a perfect complement when working with Geron Valuation or Volatility modules.

Check out the analysis of Geron Correlation against competitors.

To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.

Latest Geron's Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Geron over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Geron's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Geron's overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Geron Stock Based Compensation Regression Statistics

	Arithmetic Mean	8,842,847
	Geometric Mean	6,351,773
	Coefficient Of Variation	61.41
	Mean Deviation	3,786,155
	Median	8,001,000
	Standard Deviation	5,430,319
	Sample Variance	29.5T
	Range	20.2M
	R-Value	0.55
	Mean Square Error	22.3T
	R-Squared	0.30
	Significance	0.04
	Slope	662,053
	Total Sum of Squares	412.8T

Geron Stock Based Compensation History

	2024	20.3 M
	2023	19.4 M
	2022	8 M
	2021	8.1 M
	2020	6.9 M
	2019	6.1 M
	2018	6.4 M

Other Fundumenentals of Geron

Stock Based Compensation To Revenue

Geron Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Short Term Debt	Net Receivables	Common Stock	Long Term Debt	Short Term Investments	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Capital Surpluse	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock	Long Term Debt Total
Total Assets		0.73	0.67	-0.82	0.62	0.87	0.99	0.83	0.36	0.52	0.48	0.99	-0.13	0.58	0.2	0.77	0.42	0.72	0.84	0.84	0.81	0.58
Total Stockholder Equity	0.73		0.39	-0.61	0.24	0.39	0.68	0.36	0.07	0.56	0.12	0.77	-0.42	0.57	0.43	0.62	0.58	0.68	0.78	0.78	0.51	0.16
Net Debt	0.67	0.39		-0.54	0.71	0.71	0.64	0.52	0.34	0.15	0.76	0.66	0.17	0.16	0.2	0.72	0.5	0.63	0.76	0.75	0.74	0.69
Retained Earnings	-0.82	-0.61	-0.54		-0.65	-0.78	-0.84	-0.66	-0.46	-0.83	-0.25	-0.84	0.54	-0.84	0.15	-0.8	-0.03	-0.74	-0.65	-0.64	-0.74	-0.55
Accounts Payable	0.62	0.24	0.71	-0.65		0.82	0.63	0.57	0.75	0.32	0.58	0.56	0.1	0.3	-0.08	0.73	0.17	0.38	0.56	0.51	0.8	0.61
Total Liab	0.87	0.39	0.71	-0.78	0.82		0.9	0.88	0.62	0.35	0.65	0.82	0.07	0.39	-0.11	0.82	0.19	0.62	0.73	0.7	0.92	0.75
Total Current Assets	0.99	0.68	0.64	-0.84	0.63	0.9		0.88	0.4	0.53	0.47	0.98	-0.13	0.59	0.1	0.77	0.31	0.72	0.83	0.82	0.82	0.59
Short Term Debt	0.83	0.36	0.52	-0.66	0.57	0.88	0.88		0.45	0.26	0.46	0.78	0.13	0.34	-0.2	0.65	0.13	0.6	0.68	0.66	0.83	0.49
Net Receivables	0.36	0.07	0.34	-0.46	0.75	0.62	0.4	0.45		0.18	0.48	0.29	0.1	0.14	-0.19	0.6	-0.21	0.3	0.26	0.25	0.61	0.49
Common Stock	0.52	0.56	0.15	-0.83	0.32	0.35	0.53	0.26	0.18		-0.25	0.58	-0.84	0.99	-0.14	0.41	-0.08	0.42	0.3	0.3	0.3	0.23
Long Term Debt	0.48	0.12	0.76	-0.25	0.58	0.65	0.47	0.46	0.48	-0.25		0.44	0.48	-0.25	0.22	0.62	0.26	0.43	0.58	0.6	0.62	0.7
Short Term Investments	0.99	0.77	0.66	-0.84	0.56	0.82	0.98	0.78	0.29	0.58	0.44		-0.21	0.63	0.22	0.75	0.39	0.74	0.85	0.86	0.76	0.54
Property Plant Equipment	-0.13	-0.42	0.17	0.54	0.1	0.07	-0.13	0.13	0.1	-0.84	0.48	-0.21		-0.8	0.14	-0.17	0.23	-0.28	-0.03	-0.06	0.05	0.06
Current Deferred Revenue	0.58	0.57	0.16	-0.84	0.3	0.39	0.59	0.34	0.14	0.99	-0.25	0.63	-0.8		-0.15	0.39	-0.06	0.44	0.33	0.34	0.32	0.24
Net Tangible Assets	0.2	0.43	0.2	0.15	-0.08	-0.11	0.1	-0.2	-0.19	-0.14	0.22	0.22	0.14	-0.15		0.0	0.59	0.07	0.2	0.24	-0.16	-0.12
Capital Surpluse	0.77	0.62	0.72	-0.8	0.73	0.82	0.77	0.65	0.6	0.41	0.62	0.75	-0.17	0.39	0.0		0.24	0.85	0.84	0.82	0.92	0.59
Long Term Investments	0.42	0.58	0.5	-0.03	0.17	0.19	0.31	0.13	-0.21	-0.08	0.26	0.39	0.23	-0.06	0.59	0.24		0.22	0.59	0.55	0.3	0.1
Short Long Term Debt	0.72	0.68	0.63	-0.74	0.38	0.62	0.72	0.6	0.3	0.42	0.43	0.74	-0.28	0.44	0.07	0.85	0.22		0.77	0.77	0.74	0.43
Net Invested Capital	0.84	0.78	0.76	-0.65	0.56	0.73	0.83	0.68	0.26	0.3	0.58	0.85	-0.03	0.33	0.2	0.84	0.59	0.77		0.99	0.85	0.48
Net Working Capital	0.84	0.78	0.75	-0.64	0.51	0.7	0.82	0.66	0.25	0.3	0.6	0.86	-0.06	0.34	0.24	0.82	0.55	0.77	0.99		0.8	0.49
Capital Stock	0.81	0.51	0.74	-0.74	0.8	0.92	0.82	0.83	0.61	0.3	0.62	0.76	0.05	0.32	-0.16	0.92	0.3	0.74	0.85	0.8		0.63
Long Term Debt Total	0.58	0.16	0.69	-0.55	0.61	0.75	0.59	0.49	0.49	0.23	0.7	0.54	0.06	0.24	-0.12	0.59	0.1	0.43	0.48	0.49	0.63

Click cells to compare fundamentals

About Geron Financial Statements

Geron investors utilize fundamental indicators, such as Stock Based Compensation, to predict how Geron Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Stock Based Compensation	19.4 M	20.3 M
Stock Based Compensation To Revenue	81.66	85.75

When determining whether Geron offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Geron's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Geron Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Geron Stock:

How To Invest In Geron

Details

Is Geron Stock a good investment?

Details

What is Geron's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Geron Correlation against competitors.

To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.

You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Geron. If investors know Geron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Geron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.33)

Revenue Per Share

0.047

Quarterly Revenue Growth

171.384

Return On Assets

(0.30)

Return On Equity

(0.69)

The market value of Geron is measured differently than its book value, which is the value of Geron that is recorded on the company's balance sheet. Investors also form their own opinion of Geron's value that differs from its market value or its book value, called intrinsic value, which is Geron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Geron's market value can be influenced by many factors that don't directly affect Geron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Geron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Geron Stock Based Compensation from 2010 to 2024

Latest Geron's Stock Based Compensation Growth Pattern

Geron Stock Based Compensation Regression Statistics

Geron Stock Based Compensation History

Other Fundumenentals of Geron

Geron Stock Based Compensation component correlations

About Geron Financial Statements

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY